Finch Therapeutics Group, Inc. (FNCH)

NASDAQ: FNCH · IEX Real-Time Price · USD
2.33
0.23 (10.95%)
May 27, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Revenue
18.537.7210.15
Revenue Growth (YoY)
140.08%-23.98%-
Cost of Revenue
000.31
Gross Profit
18.537.729.84
Selling, General & Admin
21.2414.017.44
Research & Development
57.2833.1423.54
Operating Expenses
78.5247.1630.98
Operating Income
-59.99-39.44-21.14
Other Expense / Income
-1.83-0.1-0.39
Pretax Income
-58.16-39.34-20.75
Net Income
-58.16-39.34-20.75
Net Income Common
-58.16-39.34-20.75
Shares Outstanding (Basic)
3987
Shares Outstanding (Diluted)
3987
Shares Change
381.31%11.64%-
EPS (Basic)
-1.48-4.83-2.84
EPS (Diluted)
-1.48-4.83-2.84
Free Cash Flow Per Share
-2.12-4.17-2.51
Gross Margin
100.00%100.00%96.91%
Operating Margin
-323.68%-510.90%-208.21%
Profit Margin
-313.84%-509.66%-204.39%
Free Cash Flow Margin
-448.17%-439.98%-180.16%
EBITDA
-55.86-38.55-20.27
EBITDA Margin
-301.42%-499.43%-199.65%
EBIT
-58.16-39.34-20.75
EBIT Margin
-313.84%-509.66%-204.39%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).